This work is licensed under the Creative Commons Attribution 4.0 International License.
Abdel-Mannan O, Venkatesan TC, Sutcliffe AG. Paediatric sudden unexpected death in epilepsy (SUDEP): is it truly unexplained? Paediatr Child Health. 2022 Oct; 32 (10): 328-87. DOI: 10.1016/j. paed.2022.07.010Search in Google Scholar
Xu C, Gong Y, Wang Y, Chen Z. New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments. Pharmacol Ther. 2022 May; 233: 108026. DOI: 10.1016/j.pharmthera.2021.108026Search in Google Scholar
Guery D, Rheims S. Clinical management of drug resistant epilepsy: a review on current strategies. Neuropsychiatr Dis Treat. 2021 Jul; 17: 2229-42. DOI: 10.2147/NDT.S256699Search in Google Scholar
Kobylarek D, Iwanowski P, Lewandowska Z, Limphaibool N, Szafranek S, Labrzycka A, et al. Advances in the potential biomarkers of epilepsy. Front Neurol. 2019 Jul; 10: 685. DOI: 10.3389/fneur.2019.00685Search in Google Scholar
Yuan J, Ran X, Liu K, Yao C, Yao Y, Wu H, et al.. Machine learning applications on neuroimaging for diagnosis and prognosis of epilepsy: a review. J Neurosci Methods. 2022 Feb;368(4):109441. DOI: 10.1016/j.jneumeth.2021.109441Search in Google Scholar
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010 Jun; 51(6): 1069-77. DOI: 10.1111/j.1528-1167.2009.02397.xSearch in Google Scholar
Gallotto S, Seeck M. EEG biomarker candidates for the identification of epilepsy. Clin Neurophysiol Prac. 2023 Dec; 8: 32-41. DOI: 10.1016/j.cnp.2022.11.004Search in Google Scholar
Zamay TN, Zamay GS, Shnayder NA, Dmitrenko DV, Zamay SS, Yushchenko V, et al. Nucleic Acid Aptamers for Molecular Therapy of Epilepsy and Blood-Brain Barrier Damages. Mol Ther Nucleic Acids. 2020 Mar; 19: 157-67. DOI: 10.1016/j.omtn.2019.10.042Search in Google Scholar
Niraula A, Thapa S, Kunwar S, Lamsal M, Baral N, Maskey R. Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role? BMC Endocr Disord. 2018 Aug; 18: 1-5. DOI: 10.1186/s12902-018-0284-9Search in Google Scholar
Ling Y, Jiang C, Xiao Z, Shang X, Li Q, Wang B, et al. Serum adenosine deaminase activity and acute cerebral infarction: a retrospective case-control study based on 7913 participants. Aging (Albany NY). 2022 Oct; 14(21): 8719-28. DOI: 10.18632/aging.204338Search in Google Scholar
Giusti G. Adenosine deaminase. In:Bergmeyer HU (ed), Methods of Enzymatic Analysis (2nd ed). Academic Press, New York 1974, pp 1092-1099. DOI: 10.1016/B978-0-12-091302-2.50108-0Search in Google Scholar
Surguchov A, Surgucheva I, Sharma M, Sharma R, Singh V. Pore-forming proteins as mediators of novel epigenetic mechanism of epilepsy. Front Neurol. 2017 Jan; 8: 1-8. DOI: 10.3389/fneur.2017.00003Search in Google Scholar
Choi J, Kim SY, Kim H, Lim BC, Hwang H, Chae JH, et al. Serum α-synuclein and IL-1β are increased and correlated with measures of disease severity in children with epilepsy: potential prognostic biomarkers? BMC Neurol. 2020 March; 20(85): 1-11. DOI: 10.1186/s12883-020-01662-ySearch in Google Scholar
Şimşek F, Ceylan M, Aşkın S, Kızıltunç A. Serum Myeloperoxidase, Malondialdehyde, Alpha-Synuclein Levels in Patients with Epilepsy. MNJ (Malang Neurology Journal). 2021 July;7(2):93-7. DOI: 10.21776/ub.mnj.2021.007.02.2Search in Google Scholar
Rong H, Jin L, Wei W, Wang X, Xi Z. Alpha-synuclein is a potential biomarker in the serum and CSF of patients with intractable epilepsy. Seizure. 2015 Apr; 27: 6-9. DOI: 10.1016/j. seizure.2015.02.007Search in Google Scholar
Bazhanova ED, Kozlov AA, Litovchenko AV. Mechanisms of drug resistance in the pathogenesis of epilepsy: role of neuroinflammation. A literature review. Brain Sci. 2021 May; 11(5): 663. DOI: 10.3390/brainsci11050663Search in Google Scholar
Qosa H, Miller DS, Pasinelli P, Trotti D. Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders. Brain Res. 2015 Dec; 1628: 298-316. DOI: 10.1016/j. brainres.2015.07.005Search in Google Scholar
Mesraoua B, Deleu D, Kullmann DM, Shetty AK, Boon P, Perucca E, et al. Novel therapies for epilepsy in the pipeline. Epilepsy Behav. 2019 Aug; 97: 282-90. DOI: 10.1016/j.yebeh.2019.04.042Search in Google Scholar
Asadi-Pooya A, Sperling MR. Potentiation of anti-epileptic drugs effectiveness by pyronaridine in refractory epilepsy. Med Hypotheses. 2007 Mar; 69(3): 560-3. DOI: 10.1016/j. mehy.2006.12.054Search in Google Scholar
Potschka H, Fedrowitz M, Löscher W. P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neurosci Lett. 2002 Jul: 327(3); 173-6. DOI: 10.1016/S0304-3940(02)00423-8Search in Google Scholar
Baltes S, Gastens A, Fedrowitz M, Potschka H, Kaever V, Löscher W. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology. 2007 Feb; 52(2): 333-46. DOI: 10.1016/j.neuropharm.2006.07.038Search in Google Scholar
Gomes CV, Kaster MP, Tomé AR, Agostinho PM, Cunha RA. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta. 2011 May;1808(5):1380-99. DOI: 10.1016/j.bbamem.2010.12.001Search in Google Scholar
Dupere JR, Dale TJ, Starkey SJ, Xie X. The anticonvulsant BW534U87 depresses epileptiform activity in rat hippocampal slices by an adenosine-dependent mechanism and through inhibition of voltage-gated Na+ channels. Br J Pharmacol. 1999 Nov; 128(5): 1011-20. DOI: 10.1038/sj.bjp.0702881Search in Google Scholar
Southam E, Stratton SC, Sargent RS, Brackenborough KT, Duffy C, Hagan RM, et al. Broad spectrum anticonvulsant activity of BW534U87: possible role of an adenosine-dependent mechanism. Pharmacol Biochem Behav. 2002 Dec;74(1): 111-8. DOI: 10.1016/S0091-3057(02)00956-5Search in Google Scholar
de Groot M, Iyer A, Zurolo E, Anink J, Heimans JJ, Boison D, et al. Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor-associated epilepsy. Epilepsia. 2012 Jan; 53(1): 58-66. DOI: 10.1111/j.1528-1167.2011.03306.xSearch in Google Scholar
Huang J, He Y, Chen M, Du J, Li G, Li S, et al. Adenosine deaminase and adenosine kinase expression in human glioma and their correlation with glioma associated epilepsy. Mol Med Rep. 2015 Nov;12(5):6509-16. DOI: 10.3892/mmr.2015.4285Search in Google Scholar